Venture Capital
Kintan Pty Ltd provides
early stage support to a small portfolio of early stage
technology companies. The support is generally
provided as a combination of expertise and capital for
specific activities,
such as intellectual property protection, that
helps establish a pathway to more substantial funding.
Investments in the enterprises are held by Kintan or
associated entities.
Kintan's current portfolio includes:
- Loke Goup Holdings Pty Ltd, an electronic payments and loyalty company;
- Havah Therapeutics, a biotechnology company developing a novel approach to breast cancer treatment;
- IRP Health Pty Ltd, a biotechnology company developing products that utilize natural, organic compounds as antibiotic alternatives for livestock;
- Neo Stem Cell Technologies (Group) Limited, a Hong Kong based stem cell banking and R&D company;
- Wellend Health, clinics providing a large market of women the opportunity reduce their risk of breast cancer;
- Cleantech Council, provides IP and investment into clean technology projects;
Kintan is not currently seeking additions to its portfolio.
Kintan is also an advisor to Sydney based venture capital company, Innovation Capital and to venture capital company 5i Capital.
|
|
The team at 5i Capital seeks to identify and
promote cybersecurity talent across the Asia
Pacific region (ex-Greater China) that create
positive social impacts. |
News :
Havah signs
licensing agreement with Clarus Therapeutics
LOKE Series A financing
Havah Therapeutics clinical trial information
Dr Stephen Birrell of Wellend Health on ABC Radio
Havah Therapeutics awarded significant US patent for reducing breast cancer risk
